References
- Dubucquoi S., Solau‐Gervais E., Lefranc D., Marguerie L., Sibilia J., Goetz J., et al. Evaluation of anti‐citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 2004; 63: 415–9
- Sebbag M., Simon M., Vincent C., Masson‐Bessiere C., Girbal E., Durieux J. J., et al. The antiperinuclear factor and the so‐called antikeratin antibodies are the same rheumatoid arthritis‐specific autoantibodies. J Clin Invest 1995; 95: 2672–9
- Schellekens G. A., Visser H., de Jong B. A., van den Hoogen F. H., Hazes J. M., Breedveld F. C., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155–63
- Rantapaa‐Dahlqvist S., de Jong B. A., Berglin E., Hallmans G., Wadell G., Stenlund H., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741–9
- Suzuki K., Sawada T., Murakami A., Matsui T., Tohma S., Nakazono K., et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 2003; 32: 197–204
- Kroot E. J., de Jong B. A., van Leeuwen M. A., Swinkels H., van den Hoogen F. H., et al. The prognostic value of anti‐cyclic citrullinated peptide antibody in patients with recent‐onset rheumatoid arthritis. Arthritis Rheum 2000; 43: 1831–5
- Vencovsky J., Machacek S., Sedova L., Kafkova J., Gatterova J., Pesakova V., et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003; 62: 427–30
- Yamanaka H., Matsuda Y., Tanaka M. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000; 43: 852–8